| Ulcerative Colitis |
1 |
1 |
| Biologic Therapy |
0 |
0.95 |
| Clostridium Difficile Infection |
0 |
0.96 |
| Microbiome |
0 |
0.97 |
| Fecal Transplant |
0 |
0.99 |
| Inflammatory Bowel Disease |
0 |
0.48 |
| Colitis |
0 |
0.47 |
| Immunoglobulin A (IgA) |
0 |
0.16 |
| Michigan |
0 |
0.16 |
| Bacteria |
0 |
0.98 |
| Transplantation |
0 |
0.08 |
| Colorectal Cancer |
0 |
0.05 |
| Biomarker |
0 |
0.04 |
| Cancer |
0 |
0.04 |
| Diversity |
0 |
0.04 |
| Fatty Acids |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Imbalance |
0 |
0.04 |
| Interleukin |
0 |
0.04 |
| Manipulation |
0 |
0.04 |
| Metabolism |
0 |
0.04 |
| New York |
0 |
0.04 |
| Nonpharmacologic |
0 |
0.04 |
| Pathogenesis |
0 |
0.04 |
| Rectal Hemorrhage |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |